arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

ProQR Therapeutics N.V.

PRQR Health Care Biotechnology: Pharmaceutical Preparations
$2.07
Today
as of Sep 4, 16:53 ET
Last 30 days +19.65% Jul 27 → Sep 04
$1.65 $1.86 $2.07 $2.28 $2.49 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$2.06
High
$2.10
Low
$2.06
Volume
$368,448
Avg Vol
$667,741
Mkt Cap
$261M
P/E (TTM)
—
Beta
—
52w High
$3.10
52w Low
$1.33
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 4 items

Sep 2 · 12:00 PR GlobeNewswire
ProQR to Participate in Upcoming Investor Conferences in September 2026
Aug 14 · 16:46 Associated Press
ProQR: Q2 Earnings Snapshot
Aug 13 · 11:00 PR GlobeNewswire
ProQR Announces Second Quarter 2026 Operating and Financial Results
▸ Show all 4 press releases & news Free account →

Overview

52-week range
$1.33
$3.10
42% of range
Avg surprise (last 3)
-32.4%
Avg reaction (last 2)
-0.9%
0% positive
Latest IV / EM
297%
EM ±48.1% · $3 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.65$-0.38$-0.11$0.15$0.42 Actual $-0.11Est $-0.09Actual $-0.14Est $-0.08Actual $-0.15Est $-0.15 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.15 $-0.15 0.0% -36.4% -0.6% earnings
Thu Aug 7, 2025Jun/2025 $-0.14 $-0.08 -75.0% — — earnings
Thu May 8, 2025Mar/2025 $-0.11 $-0.09 -22.2% — -1.3% earnings

Implied volatility — last 90 days

45%806%1567%2329%3090% Jun 08 — IV 1980% · EM ±261.4%Jun 09 — IV 2100% · EM ±263.2%Jun 19 — IV 910% · EM ±201.1%Jun 22 — IV 1012% · EM ±211.4%Jun 23 — IV 537% · EM ±109.8%Jun 24 — IV 1048% · EM ±209.9%Jun 25 — IV 1381% · EM ±270.4%Jun 26 — IV 598% · EM ±114.4%Jun 29 — IV 308% · EM ±54.6%Jun 30 — IV 1168% · EM ±201.1%Jul 01 — IV 582% · EM ±97.1%Jul 02 — IV 1332% · EM ±215.5%Jul 03 — IV 1379% · EM ±215.5%Jul 06 — IV 1586% · EM ±219.7%Jul 07 — IV 1779% · EM ±234.9%Jul 08 — IV 1900% · EM ±238.1%Jul 09 — IV 1876% · EM ±221.6%Jul 10 — IV 915% · EM ±101.2%Jul 13 — IV 1162% · EM ±97.1%Jul 14 — IV 3090% · EM ±223.5%Jul 21 — IV 46% · EM ±10.6%Jul 24 — IV 1302% · EM ±287.8%Jul 28 — IV 387% · EM ±79.1%Jul 30 — IV 100% · EM ±19.6%Jul 31 — IV 1580% · EM ±302.3%Aug 04 — IV 889% · EM ±153.1%Aug 05 — IV 46% · EM ±7.6%Aug 10 — IV 578% · EM ±80.1%Aug 11 — IV 493% · EM ±65.1%Aug 14 — IV 1626% · EM ±179.7%Aug 17 — IV 95% · EM ±7.9%Aug 18 — IV 109% · EM ±7.9%Aug 24 — IV 148% · EM ±30.9%Aug 25 — IV 395% · EM ±80.9%Aug 26 — IV 234% · EM ±46.8%Aug 27 — IV 396% · EM ±77.6%Aug 31 — IV 238% · EM ±42.3%Sep 01 — IV 253% · EM ±43.6%Sep 02 — IV 216% · EM ±36.0%Sep 03 — IV 297% · EM ±48.1%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in